09 May 2024 --- German primary packaging manufacturer Gerresheimer has acquired a minority stake in US-based digital health company RxCap. Furthermore, Gerresheimer’s subsidiary Centor has gained exclusive distribution rights for pharmacies in the US, consisting of connected prescription vial closure devices and complementary cloud-based software. Centor is said to be the US “market leader” in prescription vials and enables smart adherence solutions through existing pharmacy workflows. “The adherence solutions from RxCap are an ideal complement to the Centor prescription vials,” says Tony Haba, senior vice president for North America at Gerresheimer.
